Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
Open Access
- 13 August 2022
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e27953
Abstract
Alopecia areata (AA) is a patchy autoimmune nonscarring hair loss. Various pathophysiological explanations are described with immune dysregulation being the most well established. In this report, we describe a 63-year-old lady with AA recurrence, in the form of AA universalis, after 32 years of remission, following administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. We also briefly reviewed published cases with similar presentations after receiving the SARS-CoV-2 vaccine.Keywords
This publication has 20 references indexed in Scilit:
- Alopecia areata: A multifactorial autoimmune conditionJournal of Autoimmunity, 2019
- Seasonal patterns in alopecia areata, totalis, and universalisJournal of the American Academy of Dermatology, 2018
- Alopecia areata: a review of disease pathogenesisBritish Journal of Dermatology, 2018
- Alopecia areataJournal of the American Academy of Dermatology, 2018
- Alopecia areata and health-related quality of life: a systematic review and meta-analysisBritish Journal of Dermatology, 2016
- Alopecia Areata After Vaccination: Recurrence with RechallengePediatric Dermatology, 2016
- Epidemiology and burden of alopecia areata: a systematic reviewClinical, Cosmetic and Investigational Dermatology, 2015
- Vaccines and autoimmunity2009
- Familial aggregation of alopecia areataJournal of the American Academy of Dermatology, 2006
- Hair Loss After Routine ImmunizationsJAMA, 1997